PEPG · PepGen Inc.
$2.99
+0.01 (+0.34%)
At close · Aug 14
Market Cap
$207.09M
Shares
69.26M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Net Income
-$89.66M
+0.4%
FY2025
Diluted EPS
-$2.12
+25.6%
FY2025
Operating Cash Flow
-$81.64M
+0.9%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| $52.8M | $71.04M | $76.48M | $68.13M | $54.08M | $19M | |
| $23.44M | $22.57M | $21.26M | $16.64M | $14.22M | $8.11M | |
| $1.3M | $1.4M | $1.5M | $1.2M | $500K | $200K | |
| $76.24M | $93.61M | $97.74M | $84.77M | $68.3M | $27.11M | |
| -$76.24M | -$93.61M | -$97.74M | -$84.77M | -$68.3M | -$27.11M | |
| $4.4M | $4.02M | $7.14M | $6.4M | $2.79M | — | |
| $4.38M | $4.01M | $7.14M | $6.21M | $2.9M | -$172K | |
| -$71.86M | -$89.61M | -$90.6M | -$78.55M | -$65.4M | -$27.28M | |
| $79.87K | $48.87K | -$617K | $73K | $3.7M | $0 | |
| -$71.94M | -$89.66M | -$89.98M | -$78.63M | -$69.1M | -$27.28M | |
| -$72.02M | -$89.67M | -$89.99M | -$78.51M | -$69.2M | -$27.26M | |
| USD/shares | — | -$2.12 | -$2.85 | -$3.30 | -$4.42 | -$30.27 |
| USD/shares | — | -$2.12 | -$2.85 | -$3.30 | -$4.42 | -$30.27 |
| shares | — | 42.22M | 31.58M | 23.8M | 15.64M | 901.11K |
| shares | — | 42.22M | 31.58M | 23.8M | 15.64M | 901.11K |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Peer median 4.35×
EV/EBIT
—
Peer median 9.33×
P/E (TTM)
—
Peer median 8.79×
Peer medians compare against the 316 similar-size Biotechnology companies (of 545 listed).
Key facts
CIK
1835597
CUSIP
713317105
13F (30d)
74 filings
73 filers
Visit website
Investor relations